Jermasek Douglas 4
4 · Unicycive Therapeutics, Inc. · Filed Jul 30, 2025
Insider Transaction Report
Form 4
Jermasek Douglas
EVP of Corporate Strategy
Transactions
- Award
Stock Options
2025-07-28+10,000→ 215,500 totalExercise: $4.71Exp: 2035-07-28→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]2,500 of the stock options vest on first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter.